RUNX1 Is Regulated by Androgen Receptor to Promote Cancer Stem Markers and Chemotherapy Resistance in Triple Negative Breast Cancer

Triple negative breast cancer (TNBC) is an aggressive breast cancer subtype for which no effective targeted therapies are available. Growing evidence suggests that chemotherapy-resistant cancer cells with stem-like properties (CSC) may repopulate the tumor. The androgen receptor (AR) is expressed in...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernández, Natalia B., Sosa, Sofía M., Roberts, Justin T., Recouvreux, María S., Rocha-Viegas, Luciana, Christenson, Jessica L., Spoelstra, Nicole S., Couto, Facundo L., Raimondi, Ana R., Richer, Jennifer K., Rubinstein, Natalia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913961/
https://www.ncbi.nlm.nih.gov/pubmed/36766786
http://dx.doi.org/10.3390/cells12030444

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913961/
https://www.ncbi.nlm.nih.gov/pubmed/36766786
http://dx.doi.org/10.3390/cells12030444

Ejemplares similares